Literature DB >> 34428048

Proximity-Dependent Biotinylation to Elucidate the Interactome of TNK2 Nonreceptor Tyrosine Kinase.

Raiha Tahir1,2,3, Anil K Madugundu4,5,6,7,8, Savita Udainiya4,7,8, Jevon A Cutler4,9, Santosh Renuse4,8,10, Li Wang8, Nicole A Pearson8, Christopher J Mitchell3, Nupam Mahajan11, Akhilesh Pandey2,4,7,12,8,10, Xinyan Wu2,4,8,13.   

Abstract

Nonreceptor tyrosine kinases (NRTKs) represent an important class of signaling molecules driving diverse cellular pathways. Aberrant expression and hyperphosphorylation of TNK2, an NRTK, have been implicated in multiple cancers. However, the exact proteins and cellular events that mediate phenotypic changes downstream of TNK2 are unclear. Biological systems that employ proximity-dependent biotinylation methods, such as BioID, are being increasingly used to map protein-protein interactions, as they provide increased sensitivity in discovering interaction partners. In this study, we employed stable isotope labeling with amino acids in cell culture and BioID coupled to the biotinylation site identification technology (BioSITe) method that we recently developed to quantitatively explore the interactome of TNK2. By performing a controlled comparative analysis between full-length TNK2 and its truncated counterpart, we were able to not only identify site-level biotinylation of previously well-established TNK2 binders and substrates including NCK1, NCK2, CTTN, and STAT3, but also discover several novel TNK2 interacting partners. We also performed co-immunoprecipitation and immunofluorescence analysis to validate the interaction between TNK2 and CLINT1, a novel TNK2 interacting protein. Overall, this work reveals the power of the BioSITe method coupled to BioID and highlights several molecules that warrant further exploration to assess their functional significance in TNK2-mediated signaling.

Entities:  

Keywords:  BioID; BioSITe; CLINT1; SILAC; TNK2; breast cancer; interactome; mass spectrometry; protein−protein interaction; proteomics

Mesh:

Substances:

Year:  2021        PMID: 34428048      PMCID: PMC8744476          DOI: 10.1021/acs.jproteome.1c00551

Source DB:  PubMed          Journal:  J Proteome Res        ISSN: 1535-3893            Impact factor:   4.466


  50 in total

1.  TNK2 gene amplification is a novel predictor of a poor prognosis in patients with gastric cancer.

Authors:  Kazuya Shinmura; Shinichiro Kiyose; Kiyoko Nagura; Hisaki Igarashi; Yusuke Inoue; Satoki Nakamura; Matsuyoshi Maeda; Megumi Baba; Hiroyuki Konno; Haruhiko Sugimura
Journal:  J Surg Oncol       Date:  2013-10-31       Impact factor: 3.454

2.  HSP90 is necessary for the ACK1-dependent phosphorylation of STAT1 and STAT3.

Authors:  Nisintha Mahendrarajah; Marina E Borisova; Sigrid Reichardt; Maren Godmann; Andreas Sellmer; Siavosh Mahboobi; Andrea Haitel; Katharina Schmid; Lukas Kenner; Thorsten Heinzel; Petra Beli; Oliver H Krämer
Journal:  Cell Signal       Date:  2017-07-21       Impact factor: 4.315

3.  Activated cdc42-associated kinase is up-regulated in non-small-cell lung cancer and necessary for FGFR-mediated AKT activation.

Authors:  Fengqing Hu; Hongcheng Liu; Xiao Xie; Ju Mei; Mingsong Wang
Journal:  Mol Carcinog       Date:  2015-05-06       Impact factor: 4.784

4.  PyQuant: A Versatile Framework for Analysis of Quantitative Mass Spectrometry Data.

Authors:  Christopher J Mitchell; Min-Sik Kim; Chan Hyun Na; Akhilesh Pandey
Journal:  Mol Cell Proteomics       Date:  2016-05-26       Impact factor: 5.911

5.  Tti1 and Tel2 are critical factors in mammalian target of rapamycin complex assembly.

Authors:  Takeshi Kaizuka; Taichi Hara; Noriko Oshiro; Ushio Kikkawa; Kazuyoshi Yonezawa; Kenji Takehana; Shun-Ichiro Iemura; Tohru Natsume; Noboru Mizushima
Journal:  J Biol Chem       Date:  2010-04-28       Impact factor: 5.157

6.  Activated tyrosine kinase Ack1 promotes prostate tumorigenesis: role of Ack1 in polyubiquitination of tumor suppressor Wwox.

Authors:  Nupam P Mahajan; Young E Whang; James L Mohler; H Shelton Earp
Journal:  Cancer Res       Date:  2005-11-15       Impact factor: 12.701

7.  Cancer-associated mutations activate the nonreceptor tyrosine kinase Ack1.

Authors:  Victoria Prieto-Echagüe; Azad Gucwa; Barbara P Craddock; Deborah A Brown; W Todd Miller
Journal:  J Biol Chem       Date:  2010-01-28       Impact factor: 5.157

8.  Identification of the SOX2 Interactome by BioID Reveals EP300 as a Mediator of SOX2-dependent Squamous Differentiation and Lung Squamous Cell Carcinoma Growth.

Authors:  Bo Ram Kim; Etienne Coyaud; Estelle M N Laurent; Jonathan St-Germain; Emily Van de Laar; Ming-Sound Tsao; Brian Raught; Nadeem Moghal
Journal:  Mol Cell Proteomics       Date:  2017-08-09       Impact factor: 5.911

9.  The Cdc42-associated kinase ACK1 is not autoinhibited but requires Src for activation.

Authors:  Wing Chan; Soon-Tuck Sit; Ed Manser
Journal:  Biochem J       Date:  2011-04-15       Impact factor: 3.857

10.  The non-receptor tyrosine kinase TNK2/ACK1 is a novel therapeutic target in triple negative breast cancer.

Authors:  Xinyan Wu; Muhammad Saddiq Zahari; Santosh Renuse; Dhanashree S Kelkar; Mustafa A Barbhuiya; Pamela L Rojas; Vered Stearns; Edward Gabrielson; Pavani Malla; Saraswati Sukumar; Nupam P Mahajan; Akhilesh Pandey
Journal:  Oncotarget       Date:  2017-01-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.